Related references
Note: Only part of the references are listed.RAGE binds C1q and enhances C1q-mediated phagocytosis
Wanchao Ma et al.
CELLULAR IMMUNOLOGY (2012)
S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
Thiruvengadam Arumugam et al.
CLINICAL CANCER RESEARCH (2012)
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1
Vivek Rai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Identifying Key Juxtamembrane Interactions in Cell Membranes Using AraC-based Transcriptional Reporter Assay (AraTM)
Pin-Chuan Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Disulfide Bonds within the C2 Domain of RAGE Play Key Roles in Its Dimerization and Biogenesis
Wen Wei et al.
PLOS ONE (2012)
The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia
Rui Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Receptor for Advanced Glycation End Products (RAGE) Prevents Endothelial Cell Membrane Resealing and Regulates F-actin Remodeling in a β-Catenin-dependent Manner
Fei Xiong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
TIRAP, an Adaptor Protein for TLR2/4, Transduces a Signal from RAGE Phosphorylated upon Ligand Binding
Masakiyo Sakaguchi et al.
PLOS ONE (2011)
Alternatively Spliced RAGEv1 Inhibits Tumorigenesis through Suppression of JNK Signaling
Anastasia Z. Kalea et al.
CANCER RESEARCH (2010)
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R. Kang et al.
CELL DEATH AND DIFFERENTIATION (2010)
The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis
Adriana Albini et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction
Hongliang Zong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Human S100A12: a novel key player in inflammation?
Jens Pietzsch et al.
AMINO ACIDS (2009)
RAGE: a novel biological and genetic marker for vascular disease
Anastasia Z. Kalea et al.
CLINICAL SCIENCE (2009)
Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene
Anastasia Z. Kalea et al.
FASEB JOURNAL (2009)
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms
Katharina A. Sterenczak et al.
GENE (2009)
Identification, classification, and expression of RAGE gene splice variants
Barry I. Hudson et al.
FASEB JOURNAL (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Altered splicing of CEACAM1 in breast cancer: Identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms
Shikha Gaur et al.
MOLECULAR CANCER (2008)
RAGE ligand upregulation of VEGF secretion in ARPE-19 cells
Wanchao Ma et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium
Ke Zen et al.
JOURNAL OF IMMUNOLOGY (2007)
The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation
Adriana Albini et al.
NATURE PROTOCOLS (2007)
RAGE and RAGE ligands in cancer
Craig D. Logsdon et al.
CURRENT MOLECULAR MEDICINE (2007)
Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects
Sho-ichi Yamagishi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression
Ai Harashima et al.
BIOCHEMICAL JOURNAL (2006)
Regulation of osteoclast function and bone mass by RAGE
Z Zhou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development
H Ishiguro et al.
PROSTATE (2005)
Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas
T Sasahira et al.
VIRCHOWS ARCHIV (2005)
Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma
UK Bhawal et al.
ONCOLOGY (2005)
Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells
IH Park et al.
MOLECULAR IMMUNOLOGY (2004)
Tissue-specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing?
C Schlueter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2003)
The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site
K Ishihara et al.
FEBS LETTERS (2003)
Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays
HL Hsieh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Glucose, glycation, and RAGE: Implications for amplification of cellular dysfunction in diabetic nephropathy
T Wendt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy
TM Wendt et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Central role of RAGE-dependent neointimal expansion in arterial restenosis
T Sakaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
H Yonekura et al.
BIOCHEMICAL JOURNAL (2003)
Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion
B Grobben et al.
CELL AND TISSUE RESEARCH (2002)
Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer
H Kuniyasu et al.
JOURNAL OF PATHOLOGY (2002)
Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion
CH Yeh et al.
DIABETES (2001)
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
A Taguchi et al.
NATURE (2000)
Share Paper
